Alexandre Prat
Université de Montréal
H-index: 85
North America-Canada
Top articles of Alexandre Prat
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries | The Lancet Child & Adolescent Health | Sifat Sharmin Izanne Roos Charles B Malpas Pietro Iaffaldano Marta Simone | 2024/5/1 |
ALCAM on human oligodendrocytes mediates CD4 T cell adhesion | Brain | Hélène Jamann Haritha L Desu Qiao-Ling Cui Alexandre Halaweh Olivier Tastet | 2024/1 |
Identity and nature of neural stem cells in the adult human subventricular zone | Iscience | Salma Baig Javad Nadaf Redouane Allache Phuong U Le Michael Luo | 2024/4/19 |
Disease-associated astrocyte epigenetic memory promotes CNS pathology | Nature | Hong-Gyun Lee Joseph M Rone Zhaorong Li Camilo Faust Akl Seung Won Shin | 2024/3/20 |
Regulation of stress granule formation in human oligodendrocytes | Nature Communications | Florian Pernin Qiao-Ling Cui Abdulshakour Mohammadnia Milton GF Fernandes Jeffery A Hall | 2024/2/19 |
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies | Therapeutic Advances in Neurological Disorders | Helmut Butzkueven Tomas Kalincik Francesco Patti Mark Slee Bianca Weinstock-Guttman | 2024/1 |
Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies | Bettina Zierfuss Catherine Larochelle Alexandre Prat | 2024/1/1 | |
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis | Multiple Sclerosis Journal | Cyrus Daruwalla Vahid Shaygannejad Serkan Ozakbas Eva Kubala Havrdova Dana Horakova | 2023/6 |
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis | European Journal of Neurology | Ibrahima Diouf Charles B Malpas Sifat Sharmin Izanne Roos Dana Horakova | 2023/4 |
Identification of astrocyte regulators by nucleic acid cytometry | Nature | Iain C Clark Michael A Wheeler Hong-Gyun Lee Zhaorong Li Liliana M Sanmarco | 2023/2/9 |
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation | JAMA neurology | Chao Zhu Tomas Kalincik Dana Horakova Zhen Zhou Katherine Buzzard | 2023/7/1 |
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis | JAMA neurology | Izanne Roos Stella Hughes Gavin McDonnell Charles B Malpas Sifat Sharmin | 2023/8/1 |
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable | Brain | Sifat Sharmin Izanne Roos Steve Simpson-Yap Charles Malpas Marina M Sánchez | 2023/11 |
Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencing | Journal of Neuroinflammation | Moein Yaqubi Adam MR Groh Marie-France Dorion Elia Afanasiev Julia Xiao Xuan Luo | 2023/5/30 |
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile | Cell Reports Medicine | Gérémy Sannier Alexandre Nicolas Mathieu Dubé Lorie Marchitto Manon Nayrac | 2023/3/21 |
Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis | JAMA neurology | Tomas Kalincik Sifat Sharmin Izanne Roos Mark S Freedman Harold Atkins | 2023/7/1 |
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity | Multiple Sclerosis and Related Disorders | Tim Spelman Dana Horakova Serkan Ozakbas Raed Alroughani Marco Onofrj | 2023/2/1 |
Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease | Multiple Sclerosis and Related Disorders | Hayet Boudjani Giulia Fadda Gabrielle Dufort Jack Antel Paul Giacomini | 2023/8/1 |
Investigation of Changes in Lymphocyte Subset Counts and their Relationship with MRI Outcomes in the Magnify-MS Study | Multiple Sclerosis and Related Disorders | Suzanne Hodgkinson Tobias Derfuss Finn Sellebjerg Patrick Vermersch Frederik Barkhof | 2023/12/1 |
Disease activity during pre-conception, pregnancy and postpartum in women with MS receiving ocrelizumab or other disease-modifying therapies in a real-world cohort | Wei Yeh Anneke Van der Walt Olga Skibina Allan Kermode Marzena Pedrini | 2023/10/1 |
